4.6 Article

Combination assay of lung cancer associated serum markers using surface-enhanced Raman spectroscopy

期刊

JOURNAL OF MATERIALS CHEMISTRY B
卷 4, 期 10, 页码 1811-1817

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/c5tb02780b

关键词

-

资金

  1. National Key Basic Research Program of China [2012CB933301]
  2. National Natural Science Foundation of China [61302027]
  3. Natural Science Foundation of Jiangsu Province of China [BK20130871]
  4. Sci-tech Support Plan of Jiangsu Province [BE2014719]
  5. Program for Changjiang Scholars and Innovative Research Team in University [IRT_15R37]
  6. Research Innovation Program for College Graduates of Jiangsu Province [SJZZ15_0107]
  7. Priority Academic Program Development of Jiangsu Higher Education Institutions [YX03001]

向作者/读者索取更多资源

The development of an ultrasensitive analysis technique for the combination assay of cancer associated markers is an effective method for the early detection of tumor. Herein, we report a highly sensitive and specific SERS-based sandwich immunoassay for the simultaneous detection of two protein markers associated with lung cancer, including carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE). Two bright SERS tags are prepared by surface modifications of flower-like gold nanoparticles with Raman molecules and target-specific antibodies, and SERS-active magnetic nanoparticles labelled with mixed antibodies are used as immune substrates for capturing the targets and further separating the sandwich structured immune complexes from the mixture. Immunoassays for joint detection of CEA and NSE using both buffer and human serum specimens are performed and the assay results indicate that the proposed SERS-based combination assay of the two markers shows good specificity and ultrahigh sensitivity. The limit of detections of CEA and NSE in human serum specimens are 1.48 pg mL(-1) and 2.04 pg mL(-1), respectively. The proposed SERS immunoassay is expected to be used for multiple-marker assays of any other tumors and to provide a reliable method for the early screening of cancers in clinic.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据